Mikako Tochigi, Shogo Shigeta, Muneaki Shimada, Shuko Miyahara, Junko Hasegawa-Minato, Yusuke Shibuya, Masumi Ishibashi, Chiaki Hashimoto, Hideki Tokunaga, Nobuo Yaegashi. Lenvatinib plus Pembrolizumab Combination Therapy for Advanced or Recurrent Endometrial Cancer: A Single-Center, Retrospective Analysis. The Tohoku journal of experimental medicine. 2024. 262. 2. 85-95
Masumi Ishibashi, Hitoshi Niikura, Motoko Ishida, Noriyuki Iwama, Hirohito Metoki, Shogo Shigeta, Tomoyuki Nagai, Hideki Tokunaga, Muneaki Shimada, Nobuo Yaegashi. Long-Term and Short-Interval Assessment of Self-Reported Urinary and Sexual Functions after Nerve-Sparing Radical Hysterectomy: A Prospective Cohort Study. The Tohoku journal of experimental medicine. 2024
Shin Nishio, Kenta Murotani, Wataru Yamagami, Shiro Suzuki, Hidekatsu Nakai, Kazuyoshi Kato, Hideki Tokunaga, Hiroyuki Nomura, Yoshihito Yokoyama, Kazuhiro Takehara, et al. Pretreatment systemic inflammatory markers predict survival in endometrial cancer: A Japanese Gynecologic Oncology Group 2043 exploratory data analysis. Gynecologic Oncology. 2024. 181. 46-53
Hiroaki Komatsu, Yuji Ikeda, Kei Kawana, Satoru Nagase, Kiyoshi Yoshino, Wataru Yamagami, Hideki Tokunaga, Kiyoko Kato, Tadashi Kimura, Daisuke Aoki, et al. Impact of COVID-19 on gynecological cancer incidence: a large cohort study in Japan. International Journal of Clinical Oncology. 2023
Shogo Shigeta, Yosuke Konno, Yoshito Terai, Tohru Morisada, Hideki Tokunaga, Tsukasa Baba, Yoichi Kobayashi, Satoru Nagase. A qualitative systematic review of the significance of adjuvant therapy in patients with low-risk endometrial cancer presenting positive peritoneal cytology: a relevant study to the guideline update for endometrial cancer by the Japan society of gynecologic oncology guideline committee. Japanese journal of clinical oncology. 2023
竹島 信宏, 安岡 稔晃, 濱西 潤三, 長谷川 幸清, 松浦 基樹, 三浦 清徳, 長尾 昌二, 中井 英勝, 田中 尚武, 徳永 英樹, et al. プラチナ製剤感受性の日本人再発卵巣癌患者を対象としたニラパリブの第II相臨床試験の最終結果(The Final Results of a Phase 2 Study of Niraparib in Japanese Patients with Platinum-Sensitive Recurrent Ovarian Cancer). 日本婦人科腫瘍学会学術講演会プログラム・抄録集. 2022. 64回. 192-192